Lansoprazole Capsule, Delayed Release
Product Images NDC 63629-2341

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 63629-2341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

The text describes the mean severity of day heartburn for evaluable patients by study day. The severity is rated on a scale from 0 to 3, where 3 indicates a severe heartburn and 0 indicates no heartburn. The study compares the effectiveness of a placebo with two different doses of Lansoprazole, a drug used to treat acid reflux. The data is presented graphically over a period of 25 days from the start of the treatment.*

FDA Label Image

Figure-2.jpg (Figure 2)

This is a table showing the mean severity of night heartburn for evaluable patients in a study. The severity is measured on a scale of 0 (none) to 3 (severe) and the data is presented for patients taking a placebo as well as those taking Lansoprazole in 15 mg and 30 mg doses. The data is tracked over 18 days from the start of treatment.*

FDA Label Image

Formula-structure.jpg (Image 01)

FDA Label Image

Label (Lbl636292341)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.